Dafydd Milton of Thermo Fisher Scientific, Runcorn, Cheshire, UK talks about the analytical challenges facing the pharmaceutical industry and developments made to overcome them.
Janet Kelsey, Editor of The Column spoke to Dafydd Milton of Thermo Fisher Scientific, Runcorn, Cheshire, UK about the analytical challenges facing the pharmaceutical industry and what developments have been made to overcome them.
Separating Impurities from Oligonucleotides Using Supercritical Fluid Chromatography
February 21st 2025Supercritical fluid chromatography (SFC) has been optimized for the analysis of 5-, 10-, 15-, and 18-mer oligonucleotides (ONs) and evaluated for its effectiveness in separating impurities from ONs.
Analyzing New Drug Modalities: An ISC 2024 Interview with Kelly Zhang
January 10th 2025At ISC 2024 in Liverpool, United Kingdom, LCGC International interviewed Kelly Zhang of Genentech about her work analyzing new drug modalities, such as mRNA, oligonucleotides, peptides, and cell and gene therapies.